Eos Energy stock falls after Fuzzy Panda issues short report
CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) CEO Ryan Khouri reported purchasing 7,000 shares of the company’s stock. The transactions, which occurred on October 31, 2025, involved the purchase of shares at a price of $0.06, for a total value of $420. Following the transaction, Khouri directly owns 7,774,756 shares of CTT Pharmaceutical Holdings, Inc.
The timing of Khouri’s purchase coincides with CTTH’s strong recent performance, with the stock posting a 26.91% return over the past week. Currently trading at $0.07, the microcap company has a market capitalization of $4.1 million and trades at a low Price/Book multiple. InvestingPro analysis shows CTTH maintains a "GREAT" financial health score of 3.73, despite not being profitable over the last twelve months. Investors seeking deeper insights can access 12 additional ProTips and comprehensive financial metrics with InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.